Stay updated with breaking news from Ten Wolde. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Boehringer Ingelheim today announced the acquisition of privatelyheld T3 Pharmaceuticals AG T3 Pharma a clinical stage Swiss biotech company for an amount of up to 450 million CHF.
Boehringer Ingelheim today announced promising 14week Phase II data for BI 690517 a novel selective aldosterone synthase inhibitor ASi.
Medicines reached a record 30 million people, driven by JARDIANCE® and OFEV® R&D investments of 5 billion EUR, or 21 percent of net sales Net sales rise 10.5 percent (currency adjusted)
Boehringer Ingelheim announced today that Cowtribe is the first recipient of investment and non-financial support from the Boehringer Ingelheim Social Engagement (BI SE) initiative, a program which aims
Growing late-stage research pipeline, addressing areas of high unmet medical need Pipeline includes areas such as rare skin disease, pulmonary fibrosis, oncology and central nervous system